We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...

This morning, the UK pharma group confirmed it had signed an agreement to buy privately-held IDRx for $1 billion upfront, ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Pfizer (NYSE:PFE) announced Tuesday it plans to sell roughly 700M ordinary shares in Haleon (NYSE:HLN) to lower its stake in ...

BL/ - The names of the most important Chief Sustainability Officers of Europe were announced at the Futur/io C ...

EU mid-market update: Red across global markets but bond selloff at forefront of damage; Macro focus on US inflation on Wed ...

In oncology, GSK has been building a portfolio of “antibody drug conjugates”, a new type of chemotherapy that aims to kill cancerous cells while sparing healthy ones. Late last year ...

Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...

We anticipate that their industry-leading approach will accelerate the discovery of new molecules against high value GSK targets with ... discovery firms are also building their own in-house ...